CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Director sold 8,000 shares at an average $509.98 ($4,079,823)
- 4 Shares withheld for taxes Chief Executive Officer gave up 42,005 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $507.22 ($5,072,165)
- 4 Open-market sale SVP - General Counsel sold 6,871 shares at an average $509.94 ($3,503,764)
- 4 Open-market sale President-Protein Sciences sold 1,538 shares at $503.07 ($773,728)
- 4 Open-market sale SVP - General Counsel sold 5,000 shares at an average $505.66 ($2,528,311)
- 4 Open-market sale Director sold 4,000 shares at $481.52 ($1,926,065)
- 10-K Report Annual Report
- 4 Open-market sale Director sold 4,000 shares at an average $485.55 ($1,942,183)
- 4 Open-market sale SVP - General Counsel sold 3,538 shares at an average $473.95 ($1,676,849)
- 4 Option exercise Chief Executive Officer acquired 921 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 12,475 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $478.90 ($4,788,992)
- 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 869 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations · Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 17 of 65 · 1,282 filings